PAPER

Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000

B J Traynor^1,*, M Alexander¹, B Corr¹, E Frost² and O Hardiman¹

¹ Department of Neurology, Beaumont Hospital, Dublin, Ireland
² The Irish MND Association, Coleraine House, Dublin, Ireland

Correspondence to:
Correspondence to:
Dr Traynor, Massachusetts General Hospital East, Cecil B. Day Lab, Building 114, Room 3125, 16th Street, Charlestown, MA 02129, USA;
btraynor{at}partners.org

Background: In recent years, there has been a paradigm shift in the method of healthcare delivery to amyotrophic lateral sclerosis (ALS) patients with the emergence of multidisciplinary ALS clinics that cater exclusively for patients with this condition. The impact of multidisciplinary management has not been previously evaluated.

Methods: Using data from the Irish ALS Register, we conducted a prospective, population based study of all ALS cases diagnosed in Ireland over a five year period to evaluate the effectiveness of a multidisciplinary clinic on ALS survival.

Results: Eighty two (24%) patients attended the multidisciplinary ALS clinic, with the remaining 262 (76%) cases followed in a general neurology clinic. The ALS clinic cohort was an average of five years younger (60.1 v 65.6 years) and were more likely to receive riluzole than the general neurology cohort (99% v 61%). The median survival of the ALS clinic cohort was 7.5 months longer than for patients in the general neurology cohort (logrank = 15.4, p < 0.0001). Overall, one year mortality was decreased by 29.7%. Prognosis of bulbar onset patients was extended by 9.6 months if they attended the ALS clinic. Using multivariate analysis, attendance at the ALS clinic was an independent covariate of survival (HR = 1.47, p = 0.02).

Conclusions: ALS patients who received their care at a multidisciplinary clinic had a better prognosis than patients attending a general neurology clinic. The data suggest that active and aggressive management enhances survival, particularly among ALS patients with bulbar dysfunction. The effect of clinic type must be considered in future clinical trials design.

Keywords: amyotrophic lateral sclerosis; Ireland; multidisciplinary clinic; survival; population based

Abbreviations: ALS, amyotrophic lateral sclerosis; IMNDA, Irish Motor Neurone Disease Association; NIPPV, non-invasive positive pressure ventilation

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Murphy, M., Quinn, S., Young, J., Parkin, P., Taylor, B. (2008). Increasing incidence of ALS in Canterbury, New Zealand: A 22-year study. Neurology 71: 1889-1895 [Abstract] [Full Text]  
• McDermott, C. J, Shaw, P. J (2008). Diagnosis and management of motor neurone disease. BMJ 336: 658-662 [Full Text]  
• Logroscino, G, Traynor, B J, Hardiman, O, Chio', A, Couratier, P, Mitchell, J D, Swingler, R J, Beghi, E, for EURALS, (2008). Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J. Neurol. Neurosurg. Psychiatry 79: 6-11 [Abstract] [Full Text]  
• Mitsumoto, H., Rabkin, J. G. (2007). Palliative Care for Patients With Amyotrophic Lateral Sclerosis: "Prepare for the Worst and Hope for the Best". JAMA 298: 207-216 [Abstract] [Full Text]  
• Sorenson, E. J., Mandrekar, J., Crum, B., Stevens, J. C. (2007). Effect of referral bias on assessing survival in ALS. Neurology 68: 600-602 [Abstract] [Full Text]  
• Cronin, S., Greenway, M. J., Ennis, S., Kieran, D., Green, A., Prehn, J.H.M., Hardiman, O. (2006). Elevated serum angiogenin levels in ALS. Neurology 67: 1833-1836 [Abstract] [Full Text]  
• Dubinsky, R., Chen, J., Lai, S.-M. (2006). Trends in hospital utilization and outcome for patients with ALS: analysis of a large U.S. cohort.. Neurology 67: 777-780 [Abstract] [Full Text]  
• Chio, A, Bottacchi, E, Buffa, C, Mutani, R, Mora, G, the PARALS, (2006). Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities. J. Neurol. Neurosurg. Psychiatry 77: 948-950 [Abstract] [Full Text]  
• Czaplinski, A., Yen, A. A., Simpson, E. P., Appel, S. H. (2006). Slower Disease Progression and Prolonged Survival in Contemporary Patients With Amyotrophic Lateral Sclerosis: Is the Natural History of Amyotrophic Lateral Sclerosis Changing?. Arch Neurol 63: 1139-1143 [Abstract] [Full Text]  
• Chi, L., Ke, Y., Luo, C., Li, B., Gozal, D., Kalyanaraman, B., Liu, R. (2006). Motor Neuron Degeneration Promotes Neural Progenitor Cell Proliferation, Migration, and Neurogenesis in the Spinal Cords of Amyotrophic Lateral Sclerosis Mice. Stem Cells 24: 34-43 [Abstract] [Full Text]  
• Van den Berg, J. P., Kalmijn, S., Lindeman, E., Veldink, J. H., de Visser, M., Van der Graaff, M. M., Wokke, J.H.J., Van den Berg, L. H. (2005). Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology 65: 1264-1267 [Abstract] [Full Text]  
• Mulvey, T. (2005). . J Oncol Pract 1: 82-83 [Full Text]  
• Forbes, R B, Colville, S, Cran, G W, Swingler, R J (2004). Unexpected decline in survival from amyotrophic lateral sclerosis/motor neurone disease. J. Neurol. Neurosurg. Psychiatry 75: 1753-1755 [Abstract] [Full Text]  
• Hutchinson, M, Galvin, R, Sweeney, B, Lynch, T, Murphy, R, Redmond, J, Traynor, B J, Hardiman, O (2004). Effect of a multidisciplinary clinic on survival in amyotrophic lateral sclerosis * Author's reply. J. Neurol. Neurosurg. Psychiatry 75: 1208-1209 [Full Text]  
• Leigh, P N, Abrahams, S, Al-Chalabi, A, Ampong, M-A, Goldstein, L H, Johnson, J, Lyall, R, Moxham, J, Mustfa, N, Rio, A, Shaw, C, Willey, E (2003). The management of motor neurone disease. J. Neurol. Neurosurg. Psychiatry 74: iv32-47 [Full Text]